ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » Internal Medicine

Top Internal Medicine Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SAMANTHA WOOD D.O.

Internal Medicine

14,520

$930K

470
396 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

24%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $61

K.T. POTTI M.D. PC

Internal Medicine

14,518

$924K

334
244 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $61

DANIEL OVERCASH MD

Internal Medicine

14,509

$1.21M

495
314 are 65+

18%
patients receiving schedule two controlled substances

Avg: 6%

21%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$84
Average prescription price

Avg: $61

INA AGRAWAL MD

Internal Medicine

14,491

$788K

416
235 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

31%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $61

RICHARD WEIN MD

Internal Medicine

14,484

$716K

420
402 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $61

REBECCA COHEN M.D.

Internal Medicine

14,442

$745K

613
487 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

21%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $61

BERNARDO LUCENA MD

Internal Medicine

14,370

$845K

477
346 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

25%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $61

TROY QUIZ M.D.

Internal Medicine

14,311

$954K

426
309 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $61

ISRAR SIDDIQI M.D.

Internal Medicine

14,295

$954K

635
449 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $61

MARY COMPTON MD

Internal Medicine

14,283

$760K

618
483 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

21%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $61

VERNON VIX MD

Internal Medicine

14,216

$756K

552
438 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $61

DIANNA BOYER M.D.

Internal Medicine

14,066

$833K

502
382 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $61

GREGORY HEUMANN MD

Internal Medicine

14,041

$762K

602
395 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $61

ANASTACIA LAGUNZAD DO

Internal Medicine

13,978

$837K

472
354 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $61

THOMAS ARMSTRONG MD

Internal Medicine

13,940

$978K

501
368 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

27%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$70
Average prescription price

Avg: $61

MARK BURKETT D.O.

Internal Medicine

13,933

$822K

555
472 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $61

JOSEPH SHEEHY MD

Internal Medicine

13,933

$950K

402
344 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $61

PAVAN AHUJA M.D.

Internal Medicine

13,932

$892K

607
528 are 65+

2%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $61

DANIEL NALIN M.D.

Internal Medicine

13,925

$655K

536
516 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $61

STEVEN HANBERG MD

Internal Medicine

13,890

$1.09M

433
254 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$79
Average prescription price

Avg: $61

MARK TATARA MD

Internal Medicine

13,871

$894K

796
693 are 65+

2%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $61

GEORGE ALCORN M.D.

Internal Medicine

13,839

$1.1M

541
386 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

23%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 25%

$79
Average prescription price

Avg: $61

KOSHY OOMMEN M.D.

Internal Medicine

13,780

$819K

450
356 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

29%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $61

MARY BIEKER MD

Internal Medicine

13,691

$702K

523
472 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $61

BAIKADI RAVINDRA MD

Internal Medicine

13,647

$827K

550
418 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

23%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $61

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank